Abstract
91. Reducing diagnostic FISH turn-around-time: A rapid pipeline for BCR::ABL1 and PML::RARA suspected leukemias
Cancer genetics, Vol.268-269(Supplement 1), p.29
11/2022
DOI: 10.1016/j.cancergen.2022.10.094
Abstract
Successful long-term outcome of patients with BCR::ABL1 positive chronic myeloid leukemia (CML) and PML::RARA positive acute promyelocytic leukemia (APL) is critically dependent on rapid cytogenetic and molecular studies. Fluorescence in situ hybridization (FISH) serves as a standard-of-care diagnostic assay in the workup of suspected BCR::ABL1 and PML::RARA positive leukemias. Nonetheless, turn-around-time for FISH results can be upwards of days, delaying highly-effective personalized treatments.
Details
- Title: Subtitle
- 91. Reducing diagnostic FISH turn-around-time: A rapid pipeline for BCR::ABL1 and PML::RARA suspected leukemias
- Creators
- Angela LagerNifang NiuRachel Sears
- Resource Type
- Abstract
- Publication Details
- Cancer genetics, Vol.268-269(Supplement 1), p.29
- DOI
- 10.1016/j.cancergen.2022.10.094
- ISSN
- 2210-7762
- Language
- English
- Date published
- 11/2022
- Academic Unit
- Stead Family Department of Pediatrics; Medical Genetics and Genomics
- Record Identifier
- 9984701838602771
Metrics
4 Record Views